Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Dezember 2025 07:00 ET | Quelle: Nutriband Inc.

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Fentanyl designation Response
03. September 2025 16:01 ET | Quelle: Nutriband Inc.

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

warrant conversion
18. August 2025 09:00 ET | Quelle: Nutriband Inc.

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Presentation announcement
18. Juli 2025 09:15 ET | Quelle: Nutriband Inc.

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Dividend dates reminder
02. Juli 2025 08:05 ET | Quelle: Nutriband Inc.

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Stock dividend
18. Juni 2025 07:00 ET | Quelle: Nutriband Inc.

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Commercial Scale up complete for AVERSA
09. Juni 2025 07:30 ET | Quelle: Nutriband Inc.

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

New Patent issuance
03. Juni 2025 08:00 ET | Quelle: Nutriband Inc.

Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference

noble conference announcement
02. Juni 2025 08:00 ET | Quelle: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Q1 results
30. April 2025 07:30 ET | Quelle: Nutriband Inc.

Nutriband CEO Publishes Letter to Shareholders

2025 Letter to Shareholders